Melanoma is an aggressive skin cancer that is not alien to us young people, according to research that has dealt with inventory of existing cases and the age of the patients, showed that 25% of new cases involves under 30. What seems far from us as a tumor, in reality it is not that much, that's why we must be careful and see a dermatologist if there are any suspicious spots or changing size or shape.
Prevention is always the basis for everything and we must never forget it. The age of onset of melanoma has dropped significantly, according to a rough estimate, in Italy 25% of new cases involves under 30, the worrying thing is that only 10 years ago, this percentage was traveling about 5%.
To control this disease and try to understand where and how it develops, is undertaking a project to register the birth of melanoma, a project Italian Melanoma Intergroup (IMI), with the support of Bristol-Myers Squibb. Professor Carlo Riccardo Rossi, IMI President and Chief Operating Unit melanoma and sarcoma of the Oncology Institute of Veneto Padua, said: "This is the first database on this cancer in Italy.
The only similar experience in Europe is launched in Germany by the dermatologists. It is a real database to collect the number of cases and take a picture of the area, a comprehensive framework for documenting the impact and evolution of this cancer in time and in different geographical areas.
The goal is to understand how melanoma is treated in our country, identifying any areas of darkness and speaking because diagnostic and therapeutic strategies for this tumor are uniform throughout the country. " According to the medical record should be active for the summer and involve about 45 centers throughout the country. 
Prevention is always the basis for everything and we must never forget it. The age of onset of melanoma has dropped significantly, according to a rough estimate, in Italy 25% of new cases involves under 30, the worrying thing is that only 10 years ago, this percentage was traveling about 5%.
To control this disease and try to understand where and how it develops, is undertaking a project to register the birth of melanoma, a project Italian Melanoma Intergroup (IMI), with the support of Bristol-Myers Squibb. Professor Carlo Riccardo Rossi, IMI President and Chief Operating Unit melanoma and sarcoma of the Oncology Institute of Veneto Padua, said: "This is the first database on this cancer in Italy.
The only similar experience in Europe is launched in Germany by the dermatologists. It is a real database to collect the number of cases and take a picture of the area, a comprehensive framework for documenting the impact and evolution of this cancer in time and in different geographical areas.
The goal is to understand how melanoma is treated in our country, identifying any areas of darkness and speaking because diagnostic and therapeutic strategies for this tumor are uniform throughout the country. " According to the medical record should be active for the summer and involve about 45 centers throughout the country.
No comments:
Post a Comment